Nipro Corporation (FRA:5FA)

Market Cap	1.41B +10.4%
Revenue (ttm)	3.60B +2.5%
Net Income	73.66M +164.1%
EPS	0.40 +164.1%
Shares Out	n/a
PE Ratio	19.12
Forward PE	n/a
Dividend	0.16 (1.91%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	8.35
Previous Close	8.35
Day's Range	8.35 - 8.40
52-Week Range	7.50 - 9.25
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products; and operates dialysis and training centers. The company’...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1947
• Employees: 38,593
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5FA

Financial Performance

In fiscal year 2026, Nipro's revenue was 660.54 billion, an increase of 2.47% compared to the previous year's 644.59 billion. Earnings were 13.50 billion, an increase of 164.11%.

Financial numbers in JPY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 17, 2026

Data Sources Report a data error